¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ [ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ] 2020³â 9¿ù Å°¿öµå ¿¬±¸µ¿Çâ TF-IDF ³×Æ®¿öÅ©ºÐ¼®
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 

 

 

[ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ]  2020³â 9¿ù Å°¿öµå ¿¬±¸µ¿Çâ TF-IDF ³×Æ®¿öÅ©ºÐ¼®

 

 

 

ÀÓ»óÀÇÇкоßÀÇ ¿¬±¸µ¿Ç⠺м®À» À§ÇÏ¿© Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbaset)¿¡¼­ ÃßÃâµÈ ³í¹®ÀڷḦ ¹ÙÅÁÀ¸·Î Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ 2020³â 9¿ù¿¡ ¹ßÇ¥ÇÑ ±¹³» Àú³Î ³í¹®°ú ¹Ì±¹ ±¹¸³º¸°Ç¿ø PubMed DB¿¡ À妽ºµÈ ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ ³í¹®À» ºÐ¼®´ë»óÀ¸·Î ÇÏ¿´À½. ÀÓ»óÀÇÇÐºÐ¾ß Å°¿öµå »óÀ§ µ¿ÇâÀº Risk, Women, General Surgery, Neoplasms, Survival Rate, Mortality, Pain, Sensitivity & Specificity, Pediatrics, Complication, Population, Adult, Genes, Recurrence, Role, Stroke, F-18 Fdg Pet, COVID-19, Drug µîÀ¸·Î ³ªÅ¸³².

 

 

               ±×¸² 1. ÀÓ»óÀÇÇÐ 9¿ù ¿¬±¸µ¿Çâ: Å°¿öµå Ŭ¶ó¿ìµå ºÐ¼®




 

Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ±¹³»¿Í ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥ÇÑ 2020³â 9¿ù ÀÇ°úÇкоßÀÇ ³í¹® Áß¿¡¼­ ÀÓ»óÀÇÇкоßÀÇ ³í¹®Àº ±¹³» Àú³Î¹ßÇ¥ 834Æí, ±¹¿Ü Àú³Î¹ßÇ¥(PubMed À妽º±âÁØ) 1,286ÆíÀ¸·Î ÃÑ 2,110ÆíÀ¸·Î ³ªÅ¸³². ÀÌ´Â Àü¿ù ÀÓ»óÀÇÇÐºÐ¾ß 2094Æí°ú ºñ±³ÇÏ¸é ºñ½ÁÇÑ Ãß¼¼·Î ³ªÅ¸³µÀ½. 9¿ù ¹ßÇ¥µÈ ÀÇ°úÇÐºÐ¾ß Àüü ³í¹® 4,296Æí Áß¿¡¼­ ÀÓ»óÀÇÇÐºÐ¾ß ³í¹®ÀÌ Â÷ÁöÇÏ´Â ºñÀ²Àº 49.1%%¸¦ Â÷ÁöÇÏ¿© °¡Àå ³ôÀº ºñÁßÀ» ³ªÅ¸³¿.

 

       

±×¸² 2. ÀÓ»óÀÇÇÐºÐ¾ß 9¿ù ¿¬±¸µ¿Çâ ÁÖ¿äÅäÇÈ°ú Å°¿öµå ³×Æ®¿öÅ©






 

Ç¥ 1. ÀÓ»óÀÇÇÐ : 9¿ù ÅäÇÈ ¸ðµ¨¸µ ÃßÃâ ¿¬±¸µ¿Çâ Å°¿öµå 

Topic1

Topic2

Topic3

Topic4

Topic5

COVID-19

Sensitivity & Specificity

Neoplasms

Mortality

Pediatrics

Genes

Pain

Survival Rate

Risk

Women

Role

Brain

Drug Therapy

Complication

Adult

Humans

General Surgery

F-18 Fdg Pet

General Surgery

Risk

Pediatrics

Hip

Exercise

Recurrence

Depression

Neoplasms

Women

Liver

Stroke

Bmi

Infant

Evaluation Studies As Topic

Recurrence

Survival Rate

Sex

Economics

Complication

General Surgery

Death

Older Adults

Asthma

Ankle

Thorax

Emergency Medical Service

Diabetes

Anti-Bacterial Agents

Exercise

Breast Neoplasms

Population

Family

 

 

9¿ù ÀÓ»óÀÇÇкоßÀÇ ±¹³», ±¹¿Ü ¹ßÇ¥µÈ ¿¬±¸µ¿ÇâºÐ¼® ÅäÇÈ ¸ðµ¨¸µ ÃßÃâ °á°ú´Â Sensitivity and Specificity, Pain, Survival Rate, Mortality, Risk µîÀÇ ÅäÇÈÀ» Áß½ÉÀ¸·Î ¿¬±¸°¡ ÁøÇàµÇ¾úÀ¸¸ç, COVID-19, »ýÁ¸·ü, »ç¸Á·ü ¹× ÅëÁõ µîÀº  ÀÓ»óÀÇÇÐºÐ¾ß ÁÖ¿ä ¿¬±¸°³³äÀ¸·Î ³ªÅ¸³². COVID-19¿¡ ´ëÇÑ ¿¬±¸´Â ÀÓ»óÀÇÇко߿¡¼­ Áö¼ÓÀûÀÎ ¿¬±¸ÁÖÁ¦·Î ³ªÅ¸³ª°í ÀÖÀ½.



 

 Ç¥ 2. 2020³â 9¿ù ÀÓ»óÀÇÇкоߠ TF-IDF(´Ü¾î°¡ÁßÄ¡) ÅäÇÈ Å°¿öµåµ¿Ç⠺м®(N=2,110)

Å°¿öµå ¼øÀ§

±¹³»Àú³Î

ÀÓ»óÀÇÇÐ

±¹¿ÜÀú³Î

ÀÓ»óÀÇÇÐ

ÀÓ»óÀÇÇÐ

 ¿¬±¸µ¿Çâ Å°¿öµå

1

Risk

Risk

Risk

2

Women

Neoplasms

Women

3

General Surgery

Survival Rate

General Surgery

4

Pain

General Surgery

Neoplasms

5

Pediatrics

Women

Survival Rate

6

Exercise

Sensitivity And Specificity

Mortality

7

Complication

Mortality

Pain

8

COVID-19

Population

Sensitivity And Specificity

9

Mortality

Recurrence

Pediatrics

10

Balance

Genes

Complication

11

Adult

Pain

Population

12

Neoplasms

Pediatrics

Adult

13

Drug

F-18 Fdg Pet

Genes

14

Sensitivity And Specificity

Adult

Recurrence

15

Older Adults

Stroke

Role

16

Humans

Role

Stroke

17

Bmi

Death

F-18 Fdg Pet

18

Population

Complication

COVID-19

19

Role

Brain

Drug

20

Drug Therapy

Drug Therapy

Exercise







 

      ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø


 

 

 


2020-10-23 ¿ÀÀü 11:14:48, Á¶È¸¼ö : 912